The limits of mRNA vaccine manufacturing are that it's a new process and the technology and supply chain required to produce it are very hard to get right. Derek Lowe does an excellent job of debunking the simplistic "Why don't they share the design" argument here:

https://blogs.sciencemag.org/pipeline/archives/2021/02/02/my...